Experimental inoculation of naive ducks with duck hepatitis B virus (D
HBV) can lead to one of three outcomes, namely, persistent viremia, tr
ansient infection with or without viremia, or no evidence of infection
. The ability of individual ducks to resolve DHBV infection was found
to be linked to the age of the duck at the time of inoculation and the
dose of inoculated virus. (1) In recently hatched ducks inoculated in
travenously (i.v.) with 4 x 10(4) DHBV DNA genomes, a switch from pers
istent viremia to transient antibody appearance was seen at an age of
inoculation between 7 and 14 days. A 25-fold increase in the dose of v
irus (1 x 10(6) DHBV genomes) delayed this switch by 7 days. (2) When
4-month-old ducks were inoculated i.v. with different doses of virus,
only those receiving the highest dose (2 x 10(11) DHBV genomes) showed
viremia and extensive viral replication and histological changes in t
he liver; 2/3 ducks in this group had a transient infection, while the
third duck had viral replication and histological changes in the live
r that were still present at day 120 postinoculation (p.i.). in all du
cks receiving lower doses (1 x 10(3), 1 x 10(6), 1 x 10(9) DHBV genome
s) antibodies to Viral surface and core antigens developed without det
ectable viral replication in the liver on days 6, 9, or 12 p.i. (3) Wh
en 10- to 16-month-old ducks were inoculated i.v. with 2 X 10(11) DHBV
genomes, all showed extensive viral replication in hepatocytes and mi
ld to moderate histological changes in the liver on days 4 or 6 p.i. I
n 4/5 ducks viremia was not detected, anti-surface antibodies were fir
st detected on day 8 p.i., and viral DNA and antigen were cleared from
the liver by days 35-47 p.i. The remaining duck became viremic with p
ersistence of virus in the liver until at least day 46 p.i. The findin
gs of the study are consistent with a model for noncytopathic viruses
(R. M. Zinkernagel (1996) Science 271, 173-178). (C) 1998 Academic Pre
ss.